Genta Incorporated · Berkeley Heights, NJ United States (OTC: GETA)
| 200 Connell Dr. | Phone: 908-286-9800 |
| Berkeley Heights, NJ | Fax: 908-464-1701 |
| 07922 | |
| United States | 
Map This Company |
Genta Incorporated Rankings
More Companies in These Related Industries: Company Description
Genta plays rough with cancer. The firm develops drugs, including DNA/RNA medicines and more traditional small molecule drugs, for cancer and other diseases. Lead candidate Genasense blocks production of a protein that can cause resistance to cancer treatments. The company is hoping for marketing approval of Genasense to be used in conjunction with chemotherapy by patients with lymphocytic leukemia and malignant melanoma. Genasense is also in clinical trials for treatment of other diseases, such as prostate and colon cancer. Its small molecule program yielded Ganite, an FDA-approved treatment for hypercalcemia (a potentially fatal side effect of cancer); but the company does not actively market the drug.
Genta Incorporated Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - OTC: GETA Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Employees | 22 |
Executives
14 executives listed for Genta Incorporated's Berkeley Heights, NJ location.
| Chairman and CEO | Raymond Warrell | |
|---|---|---|
| SVP and COO | W. Lloyd Sanders | |
| VP Finance | Gary Siegel |